(Q51320675)
Statements
Effect of the sodium glucose co-transporter 2 inhibitor canagliflozin on plasma volume in patients with type 2 diabetes mellitus. (English)
1 reference
S Sha
1 reference
D Polidori
1 reference
T Heise
1 reference
J Natarajan
1 reference
K Farrell
1 reference
S-S Wang
1 reference
D Sica
1 reference
P Rothenberg
1 reference
L Plum-Mörschel
1 reference
8 July 2014
1 reference
16
1 reference
11
1 reference
1087-1095
1 reference